483
UBI Pharma, Inc.UBI Pharma, Inc. – FDA 483, Oct 14, 2025
Record Details
UBI Pharma Inc. was cited for significant deficiencies in its manufacturing and quality control processes for sterile injectable drug products. Issues include unqualified visual inspection equipment, inadequate control procedures for particulate matter, failures in aseptic processing, and a dysfunctional quality control unit that neglected complaint investigations and change control. These lapses resulted in the release of potentially compromised drug products to the US market.
View Company Profile
ID · 3a306b84-362f-4c3e-848b-0abc60c4621f
Other documents for UBI Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.